Etanercept, other biologics, disease-modifying antirheumatic drugs (dmards), etc (DrugBank: Etanercept)
15 diseases告示番号 | 疾患名(ページ内リンク) | 臨床試験数 |
---|---|---|
15 | 封入体筋炎 | 0 |
28 | 全身性アミロイドーシス | 0 |
35 | 天疱瘡 | 0 |
38 | スティーヴンス・ジョンソン症候群 | 0 |
39 | 中毒性表皮壊死症 | 0 |
46 | 悪性関節リウマチ | 1 |
50 | 皮膚筋炎/多発性筋炎 | 0 |
53 | シェーグレン症候群 | 0 |
56 | ベーチェット病 | 0 |
60 | 再生不良性貧血 | 0 |
85 | 特発性間質性肺炎 | 0 |
228 | 閉塞性細気管支炎 | 0 |
271 | 強直性脊椎炎 | 0 |
285 | ファンコニ貧血 | 0 |
298 | 遺伝性膵炎 | 0 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT01932372 (ClinicalTrials.gov) | July 26, 2013 | 30/7/2013 | Tofacitinib (Xeljanz) Special Investigation for Rheumatoid Arthritis | XELJANZ (REGISTERED) TABLETS 5MG SPECIAL INVESTIGATION (ALL-CASES SURVEILLANCE) | Rheumatoid Arthritis | Drug: Tofacitinib (Xeljanz);Drug: Etanercept, other Biologics, Disease-modifying antirheumatic drugs (DMARDs), etc | Pfizer | NULL | Active, not recruiting | N/A | N/A | All | 9968 | Japan |